BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 15, 2025
See today's BioWorld
Home
» Beating Drug Development Odds Very Possible, if You Know How
To read the full story,
subscribe
or
sign in
.
Beating Drug Development Odds Very Possible, if You Know How
Jan. 2, 2013
By
Anette Breindl
The FDA is your friend. Controversial as that sentiment may be among drug developers, it is the opinion of Lawrence Friedhoff, developer of Alzheimer's drug Aricept (donepezil, Pfizer Inc.) and number of other drugs.
BioWorld